{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:31:22Z","timestamp":1792279882863,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224530\/z\/21\/z"],"award-info":[{"award-number":["224530\/z\/21\/z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Identifying host factors that mediate protection against newly-emergent viruses is needed for improved pandemic preparedness. Here, we analysed pre- and early post-exposure immune factors associated with resisting SARS-CoV-2 infection after human challenge in seronegative individuals, using multiplex protein, cytometric and RNA sequencing approaches in the nasopharynx and circulation. Pre-existing cross-reactive antibodies correlate poorly with clinical outcome. Instead, protection is associated with heightened nasopharyngeal CCL13 levels locally produced by conventional dendritic cells and monocytes, along with cross-reactive T cells and less differentiated NK cells. Conditional independence network analysis implicates nasal CCL13 as the central node connected to pre-existing non-structural protein-specific T cells by CD1c\n                    <jats:sup>+<\/jats:sup>\n                    DCs. In those who became infected, baseline cross-reactive T cell and less differentiated NK cell frequencies also correlate with shorter infection duration. Thus, pre-existing mucosal chemokine levels may promote rapid innate and innate-like responses that effectively block infection. ClinicalTrials.gov identifier NCT04865237.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-67017-8","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T08:34:29Z","timestamp":1765096469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4462-7484","authenticated-orcid":false,"given":"Helen R.","family":"Wagstaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-2793","authenticated-orcid":false,"given":"Ryan S.","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin K.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-504X","authenticated-orcid":false,"given":"Rik G. H.","family":"Lindeboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5656-7634","authenticated-orcid":false,"given":"Kaylee B.","family":"Worlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-6787","authenticated-orcid":false,"given":"Lisa M.","family":"Dratva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ascough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5803-5826","authenticated-orcid":false,"given":"Loukas","family":"Papargyris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"McKendry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1205-4366","authenticated-orcid":false,"given":"Ashley M.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana-Marie","family":"Lemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Killingley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Kalinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-4604","authenticated-orcid":false,"given":"Alex","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1795-1008","authenticated-orcid":false,"given":"Andrew","family":"Catchpole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0537-6715","authenticated-orcid":false,"given":"Leo","family":"Swadling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-3047","authenticated-orcid":false,"given":"John S.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6384-1462","authenticated-orcid":false,"given":"Mala K.","family":"Maini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-0853","authenticated-orcid":false,"given":"Mahdad","family":"Noursadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6304-6848","authenticated-orcid":false,"given":"Marko Z.","family":"Nikoli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-6366","authenticated-orcid":false,"given":"Sarah A.","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-2555","authenticated-orcid":false,"given":"Peter J. M.","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-920X","authenticated-orcid":false,"given":"Christopher","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"67017_CR1","doi-asserted-by":"publisher","first-page":"ltad024","DOI":"10.1093\/immadv\/ltad024","volume":"3","author":"MVC Barnes","year":"2023","unstructured":"Barnes, M. V. C., Mandla, A., Smith, E., Maskuniitty, M. & Openshaw, P. J. M. Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022. Immunother. Adv. 3, ltad024 (2023).","journal-title":"Immunother. Adv."},{"key":"67017_CR2","doi-asserted-by":"crossref","unstructured":"Killingley, B. et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat. Med. 28, 1031\u20131041 (2022).","DOI":"10.1038\/s41591-022-01780-9"},{"key":"67017_CR3","doi-asserted-by":"crossref","unstructured":"Lindeboom, R. G. H. et al. Human SARS-CoV-2 challenge uncovers local and systemic response dynamics. Nature 631, 189\u2013198 (2024).","DOI":"10.1038\/s41586-024-07575-x"},{"key":"67017_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108500","volume":"26","author":"H Ratcliffe","year":"2023","unstructured":"Ratcliffe, H. et al. Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents. iScience 26, 108500 (2023).","journal-title":"iScience"},{"key":"67017_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108728","volume":"34","author":"AT Tan","year":"2021","unstructured":"Tan, A. T. et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID\u221219 patients. Cell Rep. 34, 108728 (2021).","journal-title":"Cell Rep."},{"key":"67017_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41591-020-01143-2","volume":"27","author":"I Schulien","year":"2021","unstructured":"Schulien, I. et al. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells. Nat. Med 27, 78\u201385 (2021).","journal-title":"Nat. Med"},{"key":"67017_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100557","volume":"3","author":"A Chandran","year":"2022","unstructured":"Chandran, A. et al. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections. Cell Rep. Med 3, 100557 (2022).","journal-title":"Cell Rep. Med"},{"key":"67017_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41586-021-04186-8","volume":"601","author":"L Swadling","year":"2022","unstructured":"Swadling, L. et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature 601, 110\u2013117 (2022).","journal-title":"Nature"},{"key":"67017_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj9285","volume":"9","author":"HR Wagstaffe","year":"2024","unstructured":"Wagstaffe, H. R. et al. Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults. Sci. Immunol. 9, eadj9285 (2024).","journal-title":"Sci. Immunol."},{"key":"67017_CR10","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","volume":"191","author":"MS Habibi","year":"2015","unstructured":"Habibi, M. S. et al. Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 191, 1040\u20131049 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"67017_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10787-013-0177-5","volume":"21","author":"E Mendez-Enriquez","year":"2013","unstructured":"Mendez-Enriquez, E. & Garc\u00eda-Zepeda, E. A. The multiple faces of CCL13 in immunity and inflammation. Inflammopharmacology 21, 397\u2013406 (2013).","journal-title":"Inflammopharmacology"},{"key":"67017_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","volume":"22","author":"NK Bj\u00f6rkstr\u00f6m","year":"2022","unstructured":"Bj\u00f6rkstr\u00f6m, N. K., Strunz, B. & Ljunggren, H.-G. Natural killer cells in antiviral immunity. Nat. Rev. Immunol. 22, 112\u2013123 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"67017_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","volume":"42","author":"H Schlums","year":"2015","unstructured":"Schlums, H. et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42, 443\u2013456 (2015).","journal-title":"Immunity"},{"key":"67017_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45412-9","volume":"13","author":"A Alrubayyi","year":"2023","unstructured":"Alrubayyi, A. et al. Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1. Sci. Rep. 13, 18994 (2023).","journal-title":"Sci. Rep."},{"key":"67017_CR15","doi-asserted-by":"crossref","unstructured":"Maucourant, C. et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci. Immunol. 5, eabd6832 (2020).","DOI":"10.1126\/sciimmunol.abd6832"},{"key":"67017_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2361019","volume":"13","author":"MZ Hasan","year":"2024","unstructured":"Hasan, M. Z. et al. SARS-CoV-2 infection induces adaptive NK cell responses by spike protein-mediated induction of HLA-E expression. Emerg. Microbes Infect. 13, 2361019 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"67017_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.trsl.2021.02.006","volume":"232","author":"C Doba\u00f1o","year":"2021","unstructured":"Doba\u00f1o, C. et al. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies. Transl. Res. 232, 60\u201374 (2021).","journal-title":"Transl. Res."},{"key":"67017_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.978440","volume":"12","author":"C Hu","year":"2022","unstructured":"Hu, C. et al. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination. Front Cell Infect. Microbiol. 12, 978440 (2022).","journal-title":"Front Cell Infect. Microbiol."},{"key":"67017_CR19","unstructured":"Shrock, E. et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science 370, eabd4250 (2020)."},{"key":"67017_CR20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1183\/09031936.00085107","volume":"32","author":"J Santiago","year":"2008","unstructured":"Santiago, J. et al. Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma. Eur. Respir. J. 32, 1243\u20131249 (2008).","journal-title":"Eur. Respir. J."},{"key":"67017_CR21","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jaci.2020.07.012","volume":"147","author":"A Jha","year":"2021","unstructured":"Jha, A. et al. Increased nasal mucosal interferon and CCL13 response to a TLR7\/8 agonist in asthma and allergic rhinitis. J. Allergy Clin. Immunol. 147, 694\u2013703.e612 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67017_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1176639","volume":"14","author":"L Li","year":"2023","unstructured":"Li, L. et al. CCL13 and human diseases. Front Immunol. 14, 1176639 (2023).","journal-title":"Front Immunol."},{"key":"67017_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik, A. & Yoshie, O. The chemokine superfamily revisited. Immunity 36, 705\u2013716 (2012).","journal-title":"Immunity"},{"key":"67017_CR24","doi-asserted-by":"crossref","unstructured":"Cab\u0103u, G. et al. Long-lasting enhanced cytokine responses following SARS-CoV-2 BNT162b2 mRNA vaccination. Vaccines (Basel) 12, 736 (2024).","DOI":"10.3390\/vaccines12070736"},{"key":"67017_CR25","doi-asserted-by":"publisher","first-page":"e0294176","DOI":"10.1371\/journal.pone.0294176","volume":"18","author":"L Bar-On","year":"2023","unstructured":"Bar-On, L., Dekel, H., Aftalion, M., Chitlaru, T. & Erez, N. Essential role for Batf3-dependent dendritic cells in regulating CD8 T-cell response during SARS-CoV-2 infection. PLoS One 18, e0294176 (2023).","journal-title":"PLoS One"},{"key":"67017_CR26","doi-asserted-by":"publisher","first-page":"101828","DOI":"10.1016\/j.smim.2023.101828","volume":"70","author":"MO Diniz","year":"2023","unstructured":"Diniz, M. O., Maini, M. K. & Swadling, L. T cell control of SARS-CoV-2: when, which, and where?. Semin Immunol. 70, 101828 (2023).","journal-title":"Semin Immunol."},{"key":"67017_CR27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41590-021-00942-0","volume":"22","author":"T Yamada","year":"2021","unstructured":"Yamada, T. et al. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Nat. Immunol. 22, 820\u2013828 (2021).","journal-title":"Nat. Immunol."},{"key":"67017_CR28","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","volume":"184","author":"S Weingarten-Gabbay","year":"2021","unstructured":"Weingarten-Gabbay, S. et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell 184, 3962\u20133980.e3917 (2021).","journal-title":"Cell"},{"key":"67017_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110167","volume":"37","author":"PA Nesterenko","year":"2021","unstructured":"Nesterenko, P. A. et al. HLA-A(\u2217)02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. Cell Rep. 37, 110167 (2021).","journal-title":"Cell Rep."},{"key":"67017_CR30","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41590-022-01292-1","volume":"23","author":"MO Diniz","year":"2022","unstructured":"Diniz, M. O. et al. Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2. Nat. Immunol. 23, 1324\u20131329 (2022).","journal-title":"Nat. Immunol."},{"key":"67017_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1164\/rccm.202103-0620OC","volume":"204","author":"S Paterson","year":"2021","unstructured":"Paterson, S. et al. Innate-like gene expression of lung-resident memory CD8(+) T cells during experimental human influenza: a clinical study. Am. J. Respir. Crit. Care Med 204, 826\u2013841 (2021).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"67017_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.697953","volume":"12","author":"E Bhagyaraj","year":"2021","unstructured":"Bhagyaraj, E. et al. Mucosal vaccination primes NK cell-dependent development of CD8(+) T cells against pulmonary brucella infection. Front Immunol. 12, 697953 (2021).","journal-title":"Front Immunol."},{"key":"67017_CR33","doi-asserted-by":"publisher","first-page":"e1012439","DOI":"10.1371\/journal.ppat.1012439","volume":"20","author":"H Balachandran","year":"2024","unstructured":"Balachandran, H. et al. NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage. PLoS Pathog. 20, e1012439 (2024).","journal-title":"PLoS Pathog."},{"key":"67017_CR34","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3389\/fimmu.2020.00812","volume":"11","author":"A Pfefferle","year":"2020","unstructured":"Pfefferle, A. et al. Deciphering natural killer cell homeostasis. Front Immunol. 11, 812 (2020).","journal-title":"Front Immunol."},{"key":"67017_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1266790","volume":"13","author":"M Claus","year":"2023","unstructured":"Claus, M. et al. Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection. Front Cell Infect. Microbiol. 13, 1266790 (2023).","journal-title":"Front Cell Infect. Microbiol."},{"key":"67017_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/imm.13432","volume":"165","author":"L Herrera","year":"2022","unstructured":"Herrera, L. et al. Identifying SARS-CoV-2 \u2018memory\u2019 NK cells from COVID\u221219 convalescent donors for adoptive cell therapy. Immunology 165, 234\u2013249 (2022).","journal-title":"Immunology"},{"key":"67017_CR37","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41436-020-01077-7","volume":"23","author":"H Vietzen","year":"2021","unstructured":"Vietzen, H. et al. Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID\u221219. Genet Med. 23, 963\u2013967 (2021).","journal-title":"Genet Med."},{"key":"67017_CR38","doi-asserted-by":"publisher","first-page":"297ra115","DOI":"10.1126\/scitranslmed.aac5722","volume":"7","author":"DM Strauss-Albee","year":"2015","unstructured":"Strauss-Albee, D. M. et al. Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility. Sci. Transl. Med. 7, 297ra115 (2015).","journal-title":"Sci. Transl. Med."},{"key":"67017_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37176-7","volume":"14","author":"D Cromer","year":"2023","unstructured":"Cromer, D. et al. Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis. Nat. Commun. 14, 1633 (2023).","journal-title":"Nat. Commun."},{"key":"67017_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S2666-5247(24)00025-9","volume":"5","author":"S Jackson","year":"2024","unstructured":"Jackson, S. et al. Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study. Lancet Microbe 5, 655\u2013668 (2024).","journal-title":"Lancet Microbe"},{"key":"67017_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2778-5","volume":"20","author":"J Candia","year":"2019","unstructured":"Candia, J. & Tsang, J. S. eNetXplorer: an R package for the quantitative exploration of elastic net families for generalized linear models. BMC Bioinforma. 20, 189 (2019).","journal-title":"BMC Bioinforma."},{"key":"67017_CR42","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1214\/009053606000000281","volume":"34","author":"N Meinshausen","year":"2006","unstructured":"Meinshausen, N. & B\u00fchlmann, P. High-dimensional graphs and variable selection with the Lasso.  Ann. Stat. 34, 1436\u20131462 (2006).","journal-title":"Ann. Stat."},{"key":"67017_CR43","first-page":"1059","volume":"13","author":"T Zhao","year":"2012","unstructured":"Zhao, T., Liu, H., Roeder, K., Lafferty, J. & Wasserman, L. The huge package for high-dimensional undirected graph estimation in R. J. Mach. Learn Res. 13, 1059\u20131062 (2012).","journal-title":"J. Mach. Learn Res."},{"key":"67017_CR44","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytom. Part A 87, 636\u2013645 (2015).","journal-title":"Cytom. Part A"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67017-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67017-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67017-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:58:32Z","timestamp":1767963512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67017-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67017"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67017-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M. and A.C. hold shares in hVIVO Services Ltd. In the past 3\u2009years, S.A.T. has received remuneration for scientific advisory board membership from Sanofi, GlaxoSmithKline, Foresite Labs and Qiagen. S.A.T. is a co-founder and holds equity in Transition Bio and Ensocell. From 8 January 2024, S.A.T. is a part-time employee of GlaxoSmithKline. P.O. declares remuneration for scientific advisory boards from Sanofi, AstraZeneca, GlaxoSmithKline, Pfizer, Seqirus, Moderna, BioNet Asia, Shionogi and IntegerBio. J.S.T. serves on the scientific advisory boards of CytoReason, ImmunoScape, and Snow Medical. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}